Stem Cell Therapy International, Inc. and Histostem Korea Announce $5 Million Financing Commitment
TAMPA, FL–(Marketwire – 11/03/09) – Stem Cell Therapy International Inc. (OTC.BB: SCII – News ) and its soon to be subsidiary, Histostem Ltd. of South Korea (”Histostem”), announced that they have entered into a definitive agreement for up to a $5 million investment commitment with Socius Life Science Capital Group, LLC. The Company’s plan is to have funds available no later than December 31 …
[Read the full article here]Related News:
International Stem Cell Corporation Signs Financing …
Stem Cell Therapy International to merge with Histostem Korea
International Stem Cell signs definitive agreement with …